Element Biosciences and Singular Genomics have often appeared to be on roughly parallel trajectories, though with key differences. Both companies launched sequencing instruments with NextSeq 2000-like specifications and largely aimed at the academic core lab and small biotech company market. At AGBT, both announced upgrades to their sequencing instruments that allow the instrument to perform spatial omics while still functioning as a sequencer. But there are key differences in their approach and what we know about each company and their degree of success so far in the sequencer market.
Read more »
